<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">As it happened in the past for the HIV, HCV, influenza viruses, SARS-CoV and other etiological agents, today a great effort is being devoted to the SARS-CoV-2 pandemia, showing its own peculiar protein targets. In the absence of an effective vaccine, inhibitor repurposing or 
 <italic>de novo</italic> drug design may offer an effective strategy to combat the alarming SARS-CoV-2 pandemia.
</p>
